The Cigna Group logo

The Cigna Group (CI)

Market Closed
30 Jul, 20:00
NYSE NYSE
$
297. 86
+5.69
+1.95%
$
80.16B Market Cap
16.39 P/E Ratio
5.6% Div Yield
2,648,166 Volume
24.83 Eps
$ 292.17
Previous Close
Day Range
287.46 298.71
Year Range
262.03 370.83
Want to track CI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 1 days
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs at $200 for Wegovy and Zepbound, will convince more employers to offer coverage of the drugs.

Cnbc | 2 months ago
Cigna and CVS shares fall as Trump targets ‘middlemen' in sweeping executive order against Big Pharma

Cigna and CVS shares fall as Trump targets ‘middlemen' in sweeping executive order against Big Pharma

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Nypost | 2 months ago
Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength

Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength

CI increases adjusted earnings guidance for 2025 to $29.60 per share from the previous estimate of $29.50.

Zacks | 2 months ago
Cigna (CI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Cigna (CI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 2 months ago
Cigna (CI) Q1 Earnings and Revenues Surpass Estimates

Cigna (CI) Q1 Earnings and Revenues Surpass Estimates

Cigna (CI) came out with quarterly earnings of $6.74 per share, beating the Zacks Consensus Estimate of $6.39 per share. This compares to earnings of $6.47 per share a year ago.

Zacks | 2 months ago
Cigna raises full-year profit forecast, latest to beat medical cost estimates

Cigna raises full-year profit forecast, latest to beat medical cost estimates

Cigna on Friday raised its full-year earnings forecast and beat estimates for quarterly profit, helped by strong performance in its pharmacy benefit management business and lower-than-expected medical costs in its insurance arm.

Reuters | 2 months ago
Will Declining Medical Customers Affect Cigna's Q1 Earnings?

Will Declining Medical Customers Affect Cigna's Q1 Earnings?

CI's first-quarter results are likely to have benefited from growing pharmacy revenues and fees.

Zacks | 3 months ago
Curious about Cigna (CI) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Cigna (CI) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.

Zacks | 3 months ago
Earnings Preview: Cigna (CI) Q1 Earnings Expected to Decline

Earnings Preview: Cigna (CI) Q1 Earnings Expected to Decline

Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 3 months ago
Cigna: Fewer Protests, More Potential

Cigna: Fewer Protests, More Potential

Cigna's strong growth, favorable valuation, and shareholder policies justify a "buy" rating, outperforming the S&P500 with a 37% return since May 2023. The integration of insurance with pharmacy benefit management, particularly through Evernorth, enhances cost control and customer retention, driving significant revenue growth. Despite rising medical costs and public dissatisfaction with insurers, Cigna's strategic focus on commercial health plans and PBMs mitigates risks and supports future growth.

Seekingalpha | 3 months ago
The Cigna Group: Compelling Exposure To Diversified Healthcare At A Discount Price

The Cigna Group: Compelling Exposure To Diversified Healthcare At A Discount Price

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth by reducing Medicare exposure and improving Commercial business. Despite industry challenges, Cigna achieved 8%-9% YoY EPS growth in 2023-2024, demonstrating strong cost discipline and effective management. The sale of Cigna's Medicare unit and focus on lower-cost biosimilars and streamlined care accessibility are key strategic moves for future growth.

Seekingalpha | 4 months ago
Cigna shuffles executive roles, names Ann Dennison as CFO

Cigna shuffles executive roles, names Ann Dennison as CFO

Cigna has made a series of upper management changes, which include making CFO Brian Evanko as the healthcare conglomerate's chief operating officer, and promoting his deputy Ann Dennison to the top finance role.

Reuters | 4 months ago
Loading...
Load More